Listed

TherapeuticsMD, Inc.: Form 10-Q for the period ended Sep 30, 2015

Filed with the SEC on Nov 5, 2015 and accepted by EDGAR at Nov 5, 2015, 16:15 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2015-07-01 to 2015-09-30$5.2mus-gaap:SalesRevenueNet
Revenue9 months2015-01-01 to 2015-09-30$14.5mus-gaap:SalesRevenueNet
Cost of revenue3 months2015-07-01 to 2015-09-30$1.2mus-gaap:CostOfGoodsSold
Cost of revenue9 months2015-01-01 to 2015-09-30$3.3mus-gaap:CostOfGoodsSold
Gross profit3 months2015-07-01 to 2015-09-30$4.0mus-gaap:GrossProfit
Gross profit9 months2015-01-01 to 2015-09-30$11.2mus-gaap:GrossProfit
Research and development3 months2015-07-01 to 2015-09-30$16.4mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2015-01-01 to 2015-09-30$58.8mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2015-07-01 to 2015-09-30$7.1mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2015-01-01 to 2015-09-30$20.1mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2015-07-01 to 2015-09-30−$19.5mus-gaap:OperatingIncomeLoss
Operating income9 months2015-01-01 to 2015-09-30−$67.7mus-gaap:OperatingIncomeLoss
Net income3 months2015-07-01 to 2015-09-30−$19.5mus-gaap:NetIncomeLoss
Net income9 months2015-01-01 to 2015-09-30−$67.6mus-gaap:NetIncomeLoss
Diluted EPS3 months2015-07-01 to 2015-09-30−$0.11us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2015-01-01 to 2015-09-30−$0.39us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow9 months2015-01-01 to 2015-09-30−$62.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2015-01-01 to 2015-09-30$15.6kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2015-09-30$81.1mus-gaap:Cash
Current assetsAt period end2015-09-30$87.8mus-gaap:AssetsCurrent
Total assetsAt period end2015-09-30$90.5mus-gaap:Assets
Current liabilitiesAt period end2015-09-30$11.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2015-09-30$12.9mus-gaap:Liabilities
Shareholders' equityAt period end2015-09-30$77.6mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001387131-15-003188. Last ingested by Listed: Nov 14, 2026, 19:24 ET. Listed shows no prices and gives no investment advice.